<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Johnson Pharmacare Limited has filed an initial disclosure with BSE confirming that it does not fall under the category of 'Large Corporate' as per SEBI circular dated 19th October 2023. This disclosure relates to the financial year 2025-26. The filing is a regulatory requirement under SEBI guidelines for fund raising through debt securities. The company has clarified its status as a non-large corporate entity, which means it is not subject to the enhanced disclosure and compliance requirements applicable to large corporates under this framework.
This is a routine compliance filing with no direct impact on shareholders. The company has clarified it does not qualify as a Large Corporate, so it avoids the additional obligations that would apply to larger entities raising debt.